<?xml version="1.0" encoding="UTF-8"?>
<p id="para50">Against this backdrop of an HIV response struggling to stay on track, the COVID-19 pandemic threatens to derail many HIV programmes completely and in a worst-case scenario could set many HIV programmes back by years if prolonged treatment interruptions occur. In 
 <italic>The Lancet Global Health</italic>, 
 <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S2214-109X(20)30288-6" id="interrefs20" xmlns:xlink="http://www.w3.org/1999/xlink">Alexandra Hogan</ext-link> and colleagues model the impacts of disruptions to prevention and treatment for HIV, tuberculosis, and malaria in low-income and middle-income settings. The researchers predict that over 5 years, HIV deaths could increase by 10% compared with a situation in which there was no COVID-19 pandemic.
</p>
